Jane Street Group, LLC Adaptive Biotechnologies Corp Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 504,277 shares of ADPT stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
504,277
Previous 1,021,533 50.64%
Holding current value
$2.37 Million
Previous $3.7 Million 30.19%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.37 - $5.12 $1.74 Million - $2.65 Million
-517,256 Reduced 50.64%
504,277 $2.58 Million
Q2 2024

Aug 14, 2024
BUY
$2.34 - $3.96 $2.16 Million - $3.66 Million
923,848 Added 945.74%
1,021,533 $3.7 Million
Q1 2024

May 15, 2024
SELL
$2.88 - $4.8 $226,209 - $377,016
-78,545 Reduced 44.57%
97,685 $313,000
Q4 2023

Feb 14, 2024
BUY
$3.46 - $5.33 $499,153 - $768,927
144,264 Added 451.3%
176,230 $863,000
Q3 2023

Nov 14, 2023
SELL
$5.07 - $8.44 $242,974 - $404,478
-47,924 Reduced 59.99%
31,966 $174,000
Q2 2023

Aug 14, 2023
BUY
$6.19 - $8.78 $259,367 - $367,890
41,901 Added 110.3%
79,890 $536,000
Q1 2023

May 15, 2023
SELL
$7.8 - $10.11 $240,762 - $312,065
-30,867 Reduced 44.83%
37,989 $335,000
Q4 2022

Feb 14, 2023
BUY
$6.26 - $9.34 $319,554 - $476,778
51,047 Added 286.64%
68,856 $526,000
Q3 2022

Nov 14, 2022
BUY
$6.5 - $12.67 $115,758 - $225,640
17,809 New
17,809 $127,000
Q2 2022

Aug 16, 2022
SELL
$6.4 - $14.73 $1.46 Million - $3.37 Million
-228,889 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$10.12 - $28.9 $2.13 Million - $6.08 Million
210,530 Added 1146.74%
228,889 $3.18 Million
Q4 2021

Feb 15, 2022
SELL
$25.17 - $36.85 $268,941 - $393,742
-10,685 Reduced 36.79%
18,359 $516,000
Q3 2021

Nov 16, 2021
BUY
$30.02 - $39.87 $523,879 - $695,771
17,451 Added 150.53%
29,044 $987,000
Q2 2021

Aug 16, 2021
SELL
$32.22 - $44.59 $1.29 Million - $1.78 Million
-40,019 Reduced 77.54%
11,593 $473,000
Q1 2021

May 18, 2021
BUY
$37.26 - $67.74 $1.53 Million - $2.79 Million
41,144 Added 393.05%
51,612 $2.08 Million
Q4 2020

Feb 17, 2021
SELL
$45.01 - $65.47 $1.93 Million - $2.8 Million
-42,789 Reduced 80.34%
10,468 $619,000
Q3 2020

Nov 17, 2020
BUY
$35.79 - $48.81 $1.15 Million - $1.57 Million
32,229 Added 153.27%
53,257 $2.59 Million
Q2 2020

Aug 17, 2020
BUY
$24.95 - $48.38 $252,793 - $490,186
10,132 Added 92.99%
21,028 $1.02 Million
Q1 2020

May 15, 2020
BUY
$16.96 - $34.16 $184,796 - $372,207
10,896 New
10,896 $303,000

Others Institutions Holding ADPT

# of Institutions
201
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email